𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response

✍ Scribed by C. D. Howell; L. S. Jeffers; W. Cassidy; K. R. Reddy; S. Hu; J. S. Lee

Book ID
108885856
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
111 KB
Volume
13
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of insulin resistance with met
Treatment of insulin resistance with metformin in naΓ―ve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin
✍ Manuel Romero-GΓ³mez; MoisΓ©s Diago; RaΓΊl J. Andrade; JosΓ© L. Calleja; Javier Salm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 1 views

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12

Randomized trial of peginterferon alfa-2
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response
✍ Maria Buti; Yoav Lurie; Natalia G. Zakharova; Natalia P. Blokhina; Andrzej Horba πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 197 KB πŸ‘ 2 views

The benefit of extending treatment duration with peginterferon (PEG-IFN) and ribavirin (RBV) from 48 weeks to 72 weeks for patients with chronic hepatitis C genotype 1 infection has not been well established. In this prospective, international, open-label, randomized, multicenter study, 1,428 treatm